{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:02:49Z","timestamp":1786993369440,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21uk1024002"],"award-info":[{"award-number":["JP21uk1024002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18dm0307002"],"award-info":[{"award-number":["JP18dm0307002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22dk0307112"],"award-info":[{"award-number":["JP22dk0307112"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21dk0307103"],"award-info":[{"award-number":["JP21dk0307103"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0425012"],"award-info":[{"award-number":["JP21wm0425012"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["3\\u20131"],"award-info":[{"award-number":["3\\u20131"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H03611"],"award-info":[{"award-number":["JP20H03611"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jpsychires.2025.03.054","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:04:36Z","timestamp":1743264276000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Relationships between clinician adherence to guideline-recommended treatment and memory function in patients with schizophrenia"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9879-9492","authenticated-orcid":false,"given":"Yasushi","family":"Kawamata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9577-9640","authenticated-orcid":false,"given":"Kazutaka","family":"Ohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satsuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3834-4859","authenticated-orcid":false,"given":"Naomi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenaga","family":"Yamamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7827-4146","authenticated-orcid":false,"given":"Kentaro","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Kodaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4228-3208","authenticated-orcid":false,"given":"Junya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yasui-Furukori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2025.03.054_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/JCP.0000000000000790","article-title":"The impact of medication anticholinergic burden on cognitive performance in people with schizophrenia","volume":"37","author":"Ang","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/YCO.0b013e32835d9efb","article-title":"Polypharmacy for schizophrenia","volume":"26","author":"Ballon","year":"2013","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/0004867419835028","article-title":"Adjunctive use of anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials","volume":"53","author":"Cho","year":"2019","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13803395.2018.1488952","article-title":"Comparing the effect of the subcategories of atypical antipsychotic medications on cognition in schizophrenia using a meta-analytic approach","volume":"41","author":"Clissold","year":"2019","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-013-1600-y","article-title":"Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis","volume":"70","author":"D\u00e9sam\u00e9ricq","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2017.03.034","article-title":"Cognitive burden of anticholinergic medications in psychotic disorders","volume":"190","author":"Eum","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib8","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/s41386-021-01057-8","article-title":"Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders","volume":"46","author":"Eum","year":"2021","journal-title":"Neuropsychopharmacology : Offic. Publ. Am. College Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00406-017-0787-9","article-title":"Benzodiazepine long-term administration is associated with impaired attention\/working memory in schizophrenia: results from the national multicentre FACE-SZ data set","volume":"268","author":"Fond","year":"2018","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/0269881114560184","article-title":"Facial affect processing deficits in schizophrenia: a meta-analysis of antipsychotic treatment effects","volume":"29","author":"Gabay","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1186\/s12888-021-03545-z","article-title":"A systematic review of the effects of psychiatric medications on social cognition","volume":"21","author":"Haime","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/pcn.13578","article-title":"Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: a multicenter study","volume":"77","author":"Hasegawa","year":"2023","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102744","article-title":"Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project","volume":"63","author":"Hashimoto","year":"2021","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12888-023-04908-4","article-title":"Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project","volume":"23","author":"Hashimoto","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1037\/0894-4105.12.3.426","article-title":"Neurocognitive deficit in schizophrenia: a quantitative review of the evidence","volume":"12","author":"Heinrichs","year":"1998","journal-title":"Neuropsychology"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0b013e318221447e","article-title":"Intercorrelations between the Personal and Social Performance Scale, cognitive function, and activities of daily living","volume":"199","author":"Hsieh","year":"2011","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/npr2.12122","article-title":"Prescription patterns in patients with schizophrenia in Japan: first-quality indicator data from the survey of \"Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)\" project","volume":"40","author":"Ichihashi","year":"2020","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/pcn.13143","article-title":"Unmet needs of patients with major depressive disorder - findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: a nationwide dissemination, education, and evaluation study","volume":"74","author":"Iida","year":"2020","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/npr2.12300","article-title":"Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: findings from the \"effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)\" project","volume":"43","author":"Iida","year":"2023","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/npr2.12293","article-title":"Development of individual fitness score for conformity of prescriptions to the \"Guidelines for Pharmacological Therapy of Schizophrenia\"","volume":"42","author":"Inada","year":"2022","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41537-023-00407-3","article-title":"Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia","volume":"9","author":"Ito","year":"2023","journal-title":"Schizophrenia (Heidelb)"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/npr2.12193","article-title":"Japanese society of Neuropsychopharmacology: \"guideline for pharmacological therapy of schizophrenia\"","volume":"41","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1192\/bjp.2020.241","article-title":"Cost and health impacts of adherence to the National Institute for Health and Care Excellence schizophrenia guideline recommendations","volume":"218","author":"Jin","year":"2021","journal-title":"Br. J. Psychiatr. : J. Ment. Sci."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1176\/appi.ajp.2020.20081212","article-title":"Anticholinergic medication burden-associated cognitive impairment in schizophrenia","volume":"178","author":"Joshi","year":"2021","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2020.177901","article-title":"The American psychiatric association practice guideline for the treatment of patients with schizophrenia","volume":"177","author":"Keepers","year":"2020","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ajp.2019.10.013","article-title":"The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophrenia","volume":"46","author":"Kim","year":"2019","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/ijnp\/pyad037","article-title":"Relationships between adherence to guideline recommendations for pharmacological therapy among clinicians and psychotic symptoms in patients with schizophrenia","volume":"26","author":"Kodaka","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41398-017-0069-3","article-title":"Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study","volume":"8","author":"Koshiyama","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12991-022-00429-8","volume":"21","author":"Kyou","year":"2022","journal-title":"Ann. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib33","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","article-title":"Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment","volume":"28","author":"McCutcheon","year":"2023","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1037\/a0014708","article-title":"Neurocognition in first-episode schizophrenia: a meta-analytic review","volume":"23","author":"Mesholam-Gately","year":"2009","journal-title":"Neuropsychology"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.euroneuro.2012.02.008","article-title":"DAI-10 is as good as DAI-30 in schizophrenia","volume":"22","author":"Nielsen","year":"2012","journal-title":"Eur. Neuropsychopharmacol. : J. Euro. College Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/acps.12374","article-title":"Second-generation antipsychotic effect on cognition in patients with schizophrenia--a meta-analysis of randomized clinical trials","volume":"131","author":"Nielsen","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/npr2.12173","article-title":"Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study","volume":"41","author":"Numata","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/npr2.12245","article-title":"Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry","volume":"42","author":"Ogasawara","year":"2022","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/JCP.0000000000001232","article-title":"Safety and efficacy in randomized controlled trials of second-generation antipsychotics versus placebo for cognitive impairments in schizophrenia: a meta-analysis","volume":"42","author":"Ohi","year":"2022","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neubiorev.2016.11.012","article-title":"A systematic review of the effect of cannabidiol on cognitive function: relevance to schizophrenia","volume":"72","author":"Osborne","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/intqhc\/12.6.475","article-title":"Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose","volume":"12","author":"Owen","year":"2000","journal-title":"Int. J. Qual. Health Care : J. Int. Soc. Qual. Health Care"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib42","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/0269881118805496","article-title":"Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia","volume":"32","author":"Santos","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S1041610219000358","article-title":"Benzodiazepine use among older adults with schizophrenia spectrum disorder: prevalence and associated factors in a multicenter study","volume":"32","author":"Schuster","year":"2020","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007967.pub2","article-title":"Acetylcholinesterase inhibitors for schizophrenia","author":"Singh","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41537-018-0064-6","article-title":"Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis","volume":"4","author":"Sinkeviciute","year":"2018","journal-title":"npj Schizophrenia"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib46","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/pcn.12911","volume":"73","author":"Takaesu","year":"2019","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/0269881105057002","article-title":"The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review","volume":"20","author":"Thornton","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib48","article-title":"European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia","volume":"65","author":"Vita","year":"2022","journal-title":"Eur. Psychiatry : J. Assoc. Euro. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib49","series-title":"The Wechsler Memory Scale-Revised","author":"Wechsler","year":"1987"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"Woodward","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib51","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1192\/bjo.2022.44","volume":"8","author":"Yamada","year":"2022","journal-title":"BJPsych open"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/npr2.12218","article-title":"Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study","volume":"42","author":"Yasui-Furukori","year":"2022","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.jpsychires.2025.03.054_bib53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0004867419893439","article-title":"Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia","volume":"54","author":"Yolland","year":"2019","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.054_bib54","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1017\/S1461145712001277","article-title":"Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis","volume":"16","author":"Zhang","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625002080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625002080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:32:58Z","timestamp":1754479978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395625002080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":53,"alternative-id":["S0022395625002080"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.03.054","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationships between clinician adherence to guideline-recommended treatment and memory function in patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.03.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}